Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
26.20
+0.01 (0.04%)
At close: Apr 18, 2025, 2:57 PM CST
SHE:301089 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Jan '20 Jan 1, 2020 | 2015 - 2019 |
Net Income | -72.77 | 243.07 | 286.54 | 65.71 | 112.8 | 61.25 | Upgrade
|
Depreciation & Amortization | 46.56 | 46.56 | 40.52 | 30.92 | 17.39 | 16.4 | Upgrade
|
Other Amortization | 0.55 | 0.55 | 0.47 | 0.57 | 0.6 | 0.17 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | -0.03 | - | 0.23 | -0 | Upgrade
|
Asset Writedown & Restructuring Costs | 4.22 | 4.22 | 1.03 | 1.34 | 0.98 | 1.69 | Upgrade
|
Loss (Gain) From Sale of Investments | -7.12 | -7.12 | -5.77 | -0.63 | -0.66 | -0.53 | Upgrade
|
Provision & Write-off of Bad Debts | 4.48 | 4.48 | -5.11 | 2.28 | 0.13 | -0.28 | Upgrade
|
Other Operating Activities | 383.5 | 11.11 | 12.48 | 9.5 | 13.92 | 12.62 | Upgrade
|
Change in Accounts Receivable | -57.67 | -57.67 | -100.76 | -27.49 | -22.27 | 44.44 | Upgrade
|
Change in Inventory | 37.75 | 37.75 | -72.92 | -21.38 | -47.43 | -29.03 | Upgrade
|
Change in Accounts Payable | -264.08 | -264.08 | 172.6 | -61.71 | -10.29 | -63.75 | Upgrade
|
Change in Unearned Revenue | - | - | - | 16.83 | 15.82 | -0.15 | Upgrade
|
Change in Other Net Operating Assets | - | - | - | 40.99 | 38.49 | 46.15 | Upgrade
|
Operating Cash Flow | 83.49 | 26.95 | 268.85 | 58.19 | 120 | 86.38 | Upgrade
|
Operating Cash Flow Growth | -67.50% | -89.98% | 361.99% | -51.51% | 38.93% | 18.32% | Upgrade
|
Capital Expenditures | -73.06 | -185.22 | -148.33 | -112.73 | -74.12 | -76.2 | Upgrade
|
Sale of Property, Plant & Equipment | 0.18 | 0.04 | 0.08 | 10 | 0.08 | 0.01 | Upgrade
|
Cash Acquisitions | - | - | - | - | - | -5.07 | Upgrade
|
Investment in Securities | -92.03 | 56.57 | -20.4 | -220 | - | - | Upgrade
|
Other Investing Activities | -3.33 | - | 6.24 | - | 0.65 | 1.11 | Upgrade
|
Investing Cash Flow | -168.23 | -128.61 | -162.41 | -322.73 | -73.39 | -80.16 | Upgrade
|
Short-Term Debt Issued | - | - | 90 | 131.4 | - | - | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 244.76 | 223.2 | Upgrade
|
Total Debt Issued | - | - | 90 | 131.4 | 244.76 | 223.2 | Upgrade
|
Short-Term Debt Repaid | - | - | - | -193.82 | - | -13.57 | Upgrade
|
Long-Term Debt Repaid | - | -40 | -115.42 | -44.93 | -228.31 | -193.9 | Upgrade
|
Total Debt Repaid | - | -40 | -115.42 | -238.75 | -228.31 | -207.47 | Upgrade
|
Net Debt Issued (Repaid) | - | -40 | -25.42 | -107.35 | 16.45 | 15.73 | Upgrade
|
Issuance of Common Stock | 21.6 | 21.6 | - | 558.81 | - | - | Upgrade
|
Common Dividends Paid | -31.61 | -50.67 | -14.98 | -7.92 | -9.6 | -13.99 | Upgrade
|
Dividends Paid | -31.61 | -50.67 | -14.98 | -7.92 | -9.6 | -13.99 | Upgrade
|
Other Financing Activities | 0.09 | - | - | -11.3 | -0.59 | -33.46 | Upgrade
|
Financing Cash Flow | -9.92 | -69.07 | -40.4 | 432.23 | 6.26 | -31.72 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.17 | 0.11 | 0.97 | -0.73 | -0.42 | 0.32 | Upgrade
|
Net Cash Flow | -94.49 | -170.62 | 67.01 | 166.97 | 52.45 | -25.18 | Upgrade
|
Free Cash Flow | 10.43 | -158.27 | 120.52 | -54.53 | 45.88 | 10.17 | Upgrade
|
Free Cash Flow Growth | -28.07% | - | - | - | 350.96% | -11.28% | Upgrade
|
Free Cash Flow Margin | 2.51% | -18.94% | 15.36% | -10.85% | 8.69% | 2.64% | Upgrade
|
Free Cash Flow Per Share | 0.08 | -1.26 | 0.95 | -0.55 | 0.48 | 0.11 | Upgrade
|
Cash Income Tax Paid | - | 237 | 56.09 | 20.74 | 29.6 | 34.8 | Upgrade
|
Levered Free Cash Flow | 139.16 | -141.8 | 106.83 | -139.19 | 58.7 | -7.51 | Upgrade
|
Unlevered Free Cash Flow | 139.19 | -141.59 | 108.94 | -133.48 | 67.37 | 1.33 | Upgrade
|
Change in Net Working Capital | -212.78 | 205.57 | -23.91 | 104.69 | -35.4 | -11.25 | Upgrade
|
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.